Maintenance hemodialysis for end-stage renal disease
Conditions
Interventions
Control group:Placebo
Sponsors
Weihai Municipal Hospital of Shandong
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years old; 2. Meet the MHD standard; 3. Can standardize the treatment of dialysis, the condition is relatively stable, and the complications and comorbid drugs can be controlled; 4. Informed and voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Surgical patients within 1 month; 2. Patients with fractures or trauma within 3 months; 3. Patients with unstable vital signs and unstable conditions; 4. Patients with severe heart failure and other critical conditions need to continue bedside hemofiltration treatment; 5. Combined with active primary malignant tumors, stroke, myocardial infarction and other serious primary diseases; 6. Patients with gastrointestinal diseases such as gastrointestinal bleeding, irritable bowel syndrome, Crohn's disease or ulcerative colitis, and patients with a history of gastrointestinal surgery; 7. Patients with a history of mental illness; 8. Patients with a history of kidney transplantation or who are scheduled to undergo a kidney transplant within 3 months; 9. Take antibiotics, glucocorticoids or other immunosuppressive agents, foods containing probiotics, prebiotics, medicines, etc. within one month; 10. Those who are allergic to the test sample or have obvious gastrointestinal symptoms such as intolerance; 11. Accept other clinical trial patients at the same time; 12. The researcher determined that the researcher could not complete the research on time...
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Protein binding toxin;Intestinal flora; | — |
Countries
China
Contacts
Public ContactYun Geng
Weihai Municipal Hospital of Shandong
Outcome results
None listed